Matthew Hoffmann

1.2k total citations
39 papers, 519 citations indexed

About

Matthew Hoffmann is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Matthew Hoffmann has authored 39 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Oncology. Recurrent topics in Matthew Hoffmann's work include Pharmacogenetics and Drug Metabolism (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Advanced Radiotherapy Techniques (5 papers). Matthew Hoffmann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Advanced Radiotherapy Techniques (5 papers). Matthew Hoffmann collaborates with scholars based in United States, Switzerland and Australia. Matthew Hoffmann's co-authors include Gondi Kumar, Sekhar Surapaneni, Claudia Kasserra, Peter Schäfer, Lori Capone, William DeMaio, Rasmy Talaat, Dawn Harper, JoAnn Scatina and John Speth and has published in prestigious journals such as Blood, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Matthew Hoffmann

38 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Hoffmann United States 13 206 162 118 71 60 39 519
Donna Skee United States 16 257 1.2× 173 1.1× 120 1.0× 87 1.2× 48 0.8× 26 959
Estelle Marrer Switzerland 11 236 1.1× 74 0.5× 83 0.7× 94 1.3× 90 1.5× 13 885
Thomas Emm United States 11 158 0.8× 219 1.4× 157 1.3× 82 1.2× 30 0.5× 16 694
Amina Haouala Switzerland 11 146 0.7× 272 1.7× 145 1.2× 27 0.4× 103 1.7× 18 591
Gaëlle Noé France 16 244 1.2× 55 0.3× 192 1.6× 61 0.9× 114 1.9× 26 615
Cecil Ross India 16 179 0.9× 327 2.0× 49 0.4× 30 0.4× 134 2.2× 51 781
Nastya Kassir United States 13 69 0.3× 80 0.5× 54 0.5× 82 1.2× 35 0.6× 46 400
Sara Salerno United States 10 397 1.9× 586 3.6× 84 0.7× 79 1.1× 41 0.7× 19 948
Robin Michelet Germany 13 164 0.8× 46 0.3× 128 1.1× 187 2.6× 94 1.6× 65 703
Bindu Murthy United States 14 64 0.3× 87 0.5× 93 0.8× 141 2.0× 13 0.2× 41 672

Countries citing papers authored by Matthew Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Matthew Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Hoffmann more than expected).

Fields of papers citing papers by Matthew Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Hoffmann. The network helps show where Matthew Hoffmann may publish in the future.

Co-authorship network of co-authors of Matthew Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Hoffmann. A scholar is included among the top collaborators of Matthew Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Hoffmann. Matthew Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Matthew, et al.. (2025). Validation of a weekly imaging protocol for tangential whole breast radiation therapy with a tattoo-less surface-guided setup. Technical Innovations & Patient Support in Radiation Oncology. 35. 100318–100318.
2.
Eade, Thomas, George Hruby, Andrew Kneebone, et al.. (2021). Assessing ISUP prostate cancer grade groups in patients treated with definitive dose escalated external beam radiation. Radiotherapy and Oncology. 162. 91–97. 4 indexed citations
3.
Hoffmann, Matthew, et al.. (2020). A critical literature review on the use of bellyboard devices to control small bowel dose for pelvic radiotherapy. Reports of Practical Oncology & Radiotherapy. 25(4). 598–605. 4 indexed citations
4.
Manley, Stephen, et al.. (2018). Application of an incident taxonomy for radiation therapy: Analysis of five years of data from three integrated cancer centres. Reports of Practical Oncology & Radiotherapy. 23(3). 220–227. 6 indexed citations
5.
Hoffmann, Matthew, et al.. (2018). Analysis of a volumetric-modulated arc therapy (VMAT) single phase prostate template as a class solution. Reports of Practical Oncology & Radiotherapy. 24(1). 92–96. 12 indexed citations
6.
Liu, Liangang, et al.. (2018). A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension. Clinical Pharmacology Advances and Applications. Volume 10. 89–99. 2 indexed citations
7.
Tong, Zeen, Usha Yerramilli, Sylvia Y.M. Yao, et al.. (2018). In vitro inhibition of human nucleoside transporters and uptake of azacitidine by an isocitrate dehydrogenase-2 inhibitor enasidenib and its metabolite AGI-16903. Xenobiotica. 49(10). 1229–1236. 1 indexed citations
8.
Westhuyzen, Justin, et al.. (2017). Software-based evaluation of a class solution for prostate IMRT planning. Reports of Practical Oncology & Radiotherapy. 22(6). 441–449. 8 indexed citations
9.
Narayanan, Rangaraj, Matthew Hoffmann, Gondi Kumar, & Sekhar Surapaneni. (2016). Application of a “Fit for Purpose” PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide. Drug Metabolism Letters. 10(3). 172–179. 9 indexed citations
10.
Liu, Hong, Rangaraj Narayanan, Matthew Hoffmann, & Sekhar Surapaneni. (2016). The Uremic Toxin Indoxyl-3-Sulfate Induces CYP1A2 In Primary Human Hepatocytes. Drug Metabolism Letters. 10(3). 195–199. 12 indexed citations
11.
Min, Myo, Benjamin Chua, Ned Abraham, et al.. (2014). Is “pelvic radiation disease” always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy?. Radiotherapy and Oncology. 110(2). 278–283. 3 indexed citations
12.
Atsriku, Christian, Matthew Hoffmann, Ying Ye, Gondi Kumar, & Sekhar Surapaneni. (2014). Metabolism and disposition of a potent and selective JNK inhibitor [14C]tanzisertib following oral administration to rats, dogs and humans. Xenobiotica. 45(5). 428–441. 5 indexed citations
13.
Li, Yan, Simon Zhou, Matthew Hoffmann, Gondi Kumar, & Maria Palmisano. (2014). Modeling and Simulation to Probe the Pharmacokinetic Disposition of Pomalidomide R- and S-Enantiomers. Journal of Pharmacology and Experimental Therapeutics. 350(2). 265–272. 11 indexed citations
14.
Atsriku, Christian, Matthew Hoffmann, Mehran F. Moghaddam, Gondi Kumar, & Sekhar Surapaneni. (2014). In vitrometabolism of a novel JNK inhibitor tanzisertib: interspecies differences in oxido-reduction and characterization of enzymes involved in metabolism. Xenobiotica. 45(6). 465–480. 4 indexed citations
15.
Hoffmann, Matthew, Claudia Kasserra, Peter Schäfer, et al.. (2012). Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration. Cancer Chemotherapy and Pharmacology. 71(2). 489–501. 98 indexed citations
16.
Hoffmann, Matthew, Gondi Kumar, Peter Schäfer, et al.. (2011). Disposition, metabolism and mass balance of [14C]apremilast following oral administration. Xenobiotica. 41(12). 1063–1075. 41 indexed citations
17.
Butera, John A., Magid Abou‐Gharbia, Hong Chen, et al.. (2009). Prodrugs of Perzinfotel with Improved Oral Bioavailability. Journal of Medicinal Chemistry. 52(3). 771–778. 27 indexed citations
18.
Boni, Joseph, Richat Abbas, Cathie Leister, et al.. (2008). Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus. Cancer Chemotherapy and Pharmacology. 64(2). 263–270. 11 indexed citations
19.
Welsby, Ian J., et al.. (2005). Recombinant activated factor VII and the anaesthetist. Anaesthesia. 60(12). 1203–1212. 17 indexed citations
20.
Bassetti, Stefano, Matthew Hoffmann, Heiner C. Bucher, Ursula Flückiger, & Manuel Battegay. (2002). Infections Requiring Hospitalization of Injection Drug Users Who Participated in an Injection Opiate Maintenance Program. Clinical Infectious Diseases. 34(5). 711–713. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Skee Breakdown of academic impact, for papers by Estelle Marrer Breakdown of academic impact, for papers by Thomas Emm Breakdown of academic impact, for papers by Amina Haouala Breakdown of academic impact, for papers by Gaëlle Noé Breakdown of academic impact, for papers by Cecil Ross Breakdown of academic impact, for papers by Nastya Kassir Breakdown of academic impact, for papers by Sara Salerno Breakdown of academic impact, for papers by Robin Michelet Breakdown of academic impact, for papers by Bindu Murthy
Rankless by CCL
2026